Name: 6th international Conference on Vascular Dementia & Movement Disorders
Start: 2023-12-04
End: 2023-12-05
Location: Dubai, UAE

Vascular Dementia Conference 2023, Vascular Dementia Congress, Alzheimer,
Neurological Disorders, Dubai, UAE

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Alzheimers-2025, France NEUROSCIENCE_2025, France Stroke Meeting 2025, France Euro Dementia 2025, Germany Mental Health Congress 2025, France

Asia Pacific & Middle East

Neuroscience-2025, UAE

Canada

Neuroscience Congress 2025, Canada Neurogenetics 2025, Canada Stroke Summit 2025, Canada

VASCULAR DEMENTIA - 2023

About Conference

We are inviting you to “6^th International Conference on Vascular Dementia & Movement Disorders” during December 04-05, 2023 Dubai, UAE

Vascular dementia is a general term describing problems with reasoning, planning, judgment, memory and other thought processes caused by brain damage from impaired blood flow to your brain.

Causes of Vascular Dementia: Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

Factors that increase your risk of heart disease and stroke — including diabetes, high blood pressure, high cholesterol and smoking. Controlling these factors may help lower your chances of developing vascular dementia

Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly; however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The prevalence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.

Benefits of attending!

Benefits to Attend Vascular Dementia 2023

Learning in a New Space
Learning with the experts
Novel techniques to benefit your research
Lectures by active practitioners
Networking with new people within your field
Keynote forums by Prominent Professors, Doctors and Physicians
Poster presentations by Young Researchers
Learning about facts and statistics to better understand the market and industry

Target Audience:

Business ambassadors
Industrial Frontrunners
Stroke Scientists, Neuro Oncologists
CEO's and Directors
Neurologist
Neurosurgeons
Psychiatrist
Neuroscientist
Head of department
Professors and Students from Academia in the research of neurological disorders

Session & Tracks

Dementia

Dementia is a wide category of brain diseases that cause an abiding and often moderate decrease in the capability to think and recall that is acute enough to affect a person's normal functioning. The most usual category of dementia is Alzheimer's disease, which makes up 50% to 70% of cases. The indications of dementia differ across types and stages of the diagnosis. The most usual affected areas are memory, visual-spatial, problem solving, language and attention. There is no known treatment for dementia. Cholinesterase inhibitors such as donepezil are frequently used and may be beneficial in moderate disorder.

Vascular Dementia and Stroke

Vascular dementia is also called multi-infarct dementia (MID) and vascular intellectual impedance. Dementia is a general term describing problems with reasoning, planning, judgment, memory and other thought processes caused by brain damage from impaired blood flow to your brain. People with Dementia give dynamic subjective hindrance, intensely or subacutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). According to a neurologist, Dementia is the second-most-common form of dementia after Alzheimer's disease (AD). . The temporal relationship between a stroke and cognitive deficits is needed to make the diagnosis. People with vascular dementia present with progressive cognitive impairment, acutely or sub acutely as in mild cognitive impairment, frequently step-wise, after multiple cerebrovascular events (strokes).

Vascular Cognitive Impairment

Vascular intellectual disability is a decrease in deduction capacities caused by a malady that harms the mind's veins. The vascular malady may cause intellectual hindrance all alone, and can likewise add to impedances in considering and conduct in a man with another cerebrum illness, for example, Alzheimer’s. Cognitive weakness normally goes with clinical disorders in Alzheimer’s related to the vascular ailment of the mind. In view of developing definitional criteria, the recurrence of subjective weakness inferable from cerebrovascular ailment is hard to decide. Dementia happens in up to 33% of elderly patients with stroke as opposed to an immaculate Dementia disorder.

Amyloid Imaging in Dementia

Amyloid-related imaging abnormalities (ARIA) are abnormal differences seen in neuroimaging of Alzheimer's disease patients, associated with amyloid-modifying therapies, particularly human monoclonal antibodies such as aducanumab. There are two types of ARIA - ARIA-E and ARIA-H. The phenomenon was first seen in trials of bapineuzumab.

Alzheimer’s disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, and loss of motivation, not managing self-care, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death

Dementia with Lewy Body (DLB)

People with Lewy body dementia have a progressive decline in their memory and ability to think; similar to Alzheimer’s disease. However, the cognitive ability or alertness of a person with Lewy body dementia is more likely to fluctuate from one moment to the next, which is not like Alzheimer’s disease. They also often have visual hallucinations (seeing things that aren’t there) and delusions (believing something that is not true). On the surface, people with Lewy body dementia often have problems with movement that resemble Parkinson’s disease. This is because the same structures of the brain are affected in Lewy body dementia and Parkinson’s disease.

Causes of Lewy Body Dementia
Symptoms of Lewy Body Dementia
Diagnosing Lewy Body
Dementia Cholinesterase Inhibitors
Diagnosing dementia (general)
Treating dementia

Neurodegenerative Diseases

Neuro degeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously

Brain Diseases

Central nervous system problems are also known as central nervous system disorders. These are the neurological problems that affect the function and structure of the brain and spinal cord, which form the central nervous system. Signs are like persistent headache; face pain, band and legs pain, inability to concentrate and slurred speech etc.

Ageing and Dementia

Aging is a main risk element for most common neurodegenerative problems, including mild cognitive impairment, dementias including cerebrovascular disease, Alzheimer's disease, Lou Gehrig's disease, and Parkinson's disease. While much research has focused on problems of aging, there are less informative studies on the molecular biology of the aging brain in the lack of neurodegenerative disease or the neuropsychological discription of healthy older adults. However, research suggests that the aging process is associated with several structural, chemical, and functional changes in the brain as well as a host of neurocognitive changes.

Dementia Care Management

Dementia care management is nothing but care provided to dementia patients at home/hospital. In-home care includes a wide range of services provided in the home, rather than in a hospital or care facility. It can allow a person with Alzheimer's or other dementia to stay in his or her own home. It also can be of great assistance to caregivers. It can allow a person with Alzheimer's or other dementia to stay in his or her own home.

Dementia Nursing

Dementia nurses can provide treatment, support and care for people with dementia and mental health problems. They might assess you at your home, and they advise you and your careers on ways of improving your health and quality of life. Dementia nurses do not normally carry out physical tasks like changing bandages or keeping saline etc. Dementia nurses will do psychological activities to care dementia patients.

Prevention of Dementia

Dementia is not a particular illness. It's a general term that portrays an extensive variety of symptoms associated with a decrease in memory or other speculation aptitudes sufficiently extreme to diminish a man's capacity to perform regular activities. Prevention of Dementia is the endeavor to abstain from creating dementia, endeavors to anticipate Dementia incorporate attempting to diminish hazard components for vascular sickness, including diabetes, hypertension, weight, smoking, and physical inertia. In Dementia vascular changes that start in brain areas that play a key role in storing and retrieving information may cause memory loss that looks very much like Alzheimer's disease

Neuropharmacology

Neuropharmacology will give information about how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior (neuro psychopharmacology), including the study of how drug dependence and addiction affect the human brain. Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function.

Novel therapeutics for Dementia:

Novel Therapeutic Technology is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT's Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient’s quality of life.

Neuro Oncology and CNS:

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.

Dementia Stages

Dynamic dementia, which is dementia that deteriorates with time, is the most widely recognized sort. Five phases of dynamic vascular dementia have been laid out. They are a piece of the Clinical Dementia Rating (CDR), which experts use to assess the movement of manifestations in patients with Dementia. Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer's disease and dementia with Lewy body’s.T he five phases depict a patient's capacity to perform in six unique zones of discernment and working: introduction, memory, judgment, home and side interests, individual care, and group.

Advances in Dementia diagnosis

Headway in treatment in Dementia is required in comprehension underlying reasons for dementia. Memory treatment has indicated great consequences for Dementia patients. Dementia is a standout amongst the most exorbitant illness in the world, this treatment is anything but difficult to lead and cheap. Memory treatment utilizes past frequencies and urges patients to compose and clarify past rates which help in keeping up psychological wellness. As misery can be one of the most reasons for Alzheimer's psychotherapy helps such patients colossally. Dementia mind through cloud innovation enables patients in monitoring their conditions and advance to rate, supporting staff and arranging in everyday mind in Dementia. Headway in such treatments utilizing innovation and characteristic treatments will help doctors to treat vascular dementia successfully. New movements have been subject of dementia gatherings and prime wellspring of learning as for dementia, these dementia social events has taken one phase closer to Dementia cure.

Market Analysis

Market Analysis

The global market for treatments of syndromes like dementia and movement disorders was valued at 10.5 billion in 2011 and was estimated to reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.

Someone in the world develops dementia every 3 seconds. There were an estimated 46.8 million people worldwide living with dementia in 2015 and this number is believed to be close to 50 million people in 2017. These numbers will almost double every 20 years, reaching 75 million in 2030 and 131.5 million in 2050. Much of the increase will be in developing countries. Already 58% of people with dementia live in low and middle income countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific neighbours.

The market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking. Perform a range of services that typically fall under general or specialty. Accounting for about 74.0% of psychotherapy in the field provide services, such as preventive care, diagnosis and treatment planning, and procedures, such psychiatry, psychotherapies, psychotherapy sciences. Psychology, which includes Sleep research, Anxiety & Stress, psychiatry, psychotherapies and cognitive Paediatric neurosciences, makes up an estimated 16.0% of practicing psychotherapy.

Mental problems will afflict one out of every four people on the planet at some point in their lives. Mental diseases (Vascular Dementia) affect around 450 million individuals globally, making them one of the most common causes of illness. Treatments are accessible, yet nearly two-thirds of persons with a diagnosable mental illness never seek professional assistance. According to the World Health Organization, stigma, prejudice, and neglect prohibit persons with mental illnesses from receiving care and treatment (WHO). There is little or no understanding where there is neglect. There is neglect when there is no comprehension. As a result, it is critical to brush up on this subject.

The global Dementia sickness market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of seventeen.5%, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics and about Alzheimer's disease, is that the commonest style of dementia.

Vascular Dementia 2023

Worldwide results of current meta-analysis reveal 44 million people (worldwide) suffered with Vascular dementia during 2010 and expected to double every 20 years, to the number 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 per cent of all people with low or middle incomes were with dementia lived in countries. This proportion anticipated in increase to 63 per cent in 2030 and 71 per cent in 2050.The values are expected to double by 2030 and triple by 2050 to 115 million. The survey reveals in United States, an estimate of many as five million people age 65 and older suffer from Dementia.

Vascular Dementia 2023

Vascular Dementia is most widely considered to be the second common cause of Alzheimer's disease, accounting for 10 % of cases. Many experts believe vascular dementia remains less diagnosed for Alzheimer's disease, even the disease is common.Alzheimer's Research UK at present funds 150 research projects across UK and focusing on developing stages which has been committed nearly £40million to dementia research.Their research focus is on improvement of the quality of life already living with Alzheimer’s disease and also other forms of dementia.

Past Conference Report

Vascular Dementia 2022

Conference Series hosted the event “5th World Conference on Vascular Dementia And Movement Disorder” during September 22-23, 2022 | London, UK. The conferences were organized with a focus on the themes “Modernization Approach by Specialist to Cure Vascular Dementia” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

The event proceedings were carried out through several Scientific-sessions and plenary lectures, Conference Series would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers of . We would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Vascular Dementia 2022.

Conference Series also took the privilege of felicitating Vascular Dementia 2022 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events.

A series of lectures by distinguished professionals discussed the recent trends and issues in inter-disciplinary Neurology and its advancements.

Save your dates for the most awaited event of 2023

With a great response and feedback which we received from participants and supporters from Vascular Dementia 2022, we are proud to announce our upcoming conferences in the Series “6th WorldConference on Vascular Dementia And Movement Disorder” on December 04-05, 2023 in Dubai, UAE

It is an International platform for business delegates, B2B meetings, poster presentations, workshops, symposia, networking and more. It will offer a platform wherein you can ensure enormous exposure and networking by exhibiting products and services. Grab the opportunities, and share your innovative ideas, new technologies and Recent researches.

Vascular Dementia 2022 witnesses an amalgamation of peerless speakers who enlightened the gathering with their contribution towards the prevention of neurology related difficulties, its effects and treatment on their disorders.

For being a Experts in Neurology and Vascular Dementia, we hope that this platform gives knowledge and new updates by undergoing with the several interactive sessions to encourage the exchange of innovative ideas in the field of Vascular Dementia and its advancements, in that all the session talks are consider to be a great talks which makes the delegates, exhibitor, collaborators and other speakers feels so much interesting.

Let’s have a look on Market study of Vascular Dementia:-

The brain illness showcase is exceedingly competitive with a parcel of players within the ring for picking up an imperative position among other players. The players are in steady interest of propelling novel items and medicines that bode well for curing a wide extend of brain infections. These headways and developments require steady investigate and development. Thus, the players within the brain illness showcase contribute intensely in investigate and improvement activities. Activities like mergers, acquisitions, joint ventures, collaborations, and organizations offer assistance the players within the brain malady advertise to fortify their position over the brain malady showcase. Extension exercises are moreover an critical portion to empower the players to find undiscovered openings.

According to United Nations agency 47.5 million folks have dementedness and each year 7.7 million new cases square measure showing. By 2030 total cases of dementia is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five million. Alzheimer’s sickness contributes 60-70 you look after cases in dementia and second commonest condition of dementedness is tube-shaped structure dementia that contributes 2 hundredth of cases everywhere the globe.

Hundreds of millions of people worldwide are affected by neurological disorders. More than 6 million people die because of stroke each year; over 80% of these deaths take place in low- and middle-income countries. More than 50 million people have epilepsy worldwide. It is estimated that there are globally 47.5 million people with dementia with 7.7 million new cases every year - Alzheimer's disease is the most common cause of dementia and may contribute to 60–70% of cases. The prevalence of migraine is more than 10% worldwide.

Vascular Dementia is most widely considered to be the second common cause of Alzheimer's disease, accounting for 10 % of cases. Many experts believe vascular dementia remains less diagnosed for Alzheimer's disease, even the disease is common. Alzheimer's Research UK at present funds 150 research projects across UK and focusing on developing stages which has been committed nearly £40million to dementia research. Their research focus is on improvement of the quality of life already living with Alzheimer’s disease and also other forms of dementia.

Paris is that the capital and most thickly settled town of France. Since seventeenth century, Paris is one of Europe’s major centers of finance, diplomacy, commerce, fashion, science and the arts. town of Paris is that the center and seat of presidency of the French region or Paris region, that has AN calculable official 2020 population of 12,213,364 or concerning eighteen percentage of the population of France. Paris is in northern central France, in a very north-bending arc of the stream Seine. Paris features a typical Western European oceanic climate. Economy of town of Paris is predicated mostly on services and commerce of the 390,480 enterprises within the town, 80.6 % square measure engaged in commerce, transportation, and various services, 6.5 % in construction and 3.9 % in business. The bulk of Paris salaried workers fill 370,000 businesses services jobs, targeted within the north-western eighth sixteenth, seventeenth arrondissements. Paris was the third-busiest airline destination within the world, with 19.03 million guests behind port and London. Paris is a global capital of fashion since the nineteenth century significantly within the domain of high fashion, covering hand-made to order for personal shoppers.

Market Overview

The key factors propelling the growth of the market are the increasing prevalence of neurological disorders like Vascular Dementia, Alzheimer huge, brain aneurysms, brain tumours, memory disorders, multiple sclerosis, Parkinson’s disease, post-herpetic neuralgia, spinal cord tumour, peripheral neuropathy, epilepsy, and stroke investments by private players in this field, increase in R&D in the field of Neuro therapies, and rising through population.

Vascular Dementia studies are utilized as a part of the treatment of neurological disorders, for example, Alzheimer infection and different dementia, epilepsy, cerebrovascular diseases, including stroke, headache, and another migraine issue, Parkinson's sickness, multiple sclerosis, Neuro infection, mind tumors, horrible disarranges of the sensory system because of head injury and neurological issue because of ailing health.

Neuro infections involve fungal, parasitic, bacterial infections, brain abscess and prion diseases.

Neurological scatters may likewise happen because of different contaminations, for example, viral disease like Zika virus, bacterial disease, and parasitic contamination.

As per the World Health Organization, in 2016, around 450 a great many individuals were influenced by neurological scatters over the world. Around 50 million individuals were accounted for to experience the ill effects of epilepsy over the globe and more than 6 million individuals kick the bucket because of a stroke every year. Brain health devices, for example, CT filter, MRI, EEG, MEG, Transcranial Doppler gadgets are generally used to screen mind movement.

The report includes:

Analyses of the global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates through 2024, Historical background on neurological disorders and therapeutics, growing prevalence of neurological disorders, increasing research and development activities regarding neurology research in Vascular dementia, and analysis of the factors influencing the market. Quantitative analysis of the neurology therapeutics market covering Parkinson Diseases, Alzheimer Diseases, Psychotic Disorders, Epileptic Disorders, Autism Disorders, and Brain Tumor Diseases

According to the World Health Organization, around 300 million individuals worldwide suffer from depression, anxiety, and stress. The rapid prevalence of depression and anxiety disorders is the first driver of the global anxiety disorders and depression therapy industry.

The rising elderly population, increasing affectivity, and decreasing facet effects of medicine in several categories are further pushing the global anxiety disorders and depression treatment market. Depression affects 10 to 15 percent of males and 15 to 25 percent of women.

At the time of identification, 35 percent of people had depression, anxiety, or both (including borderline cases), and 29 percent had it three months later, dropping to Revolutionary Organization. The annual prevalence rates were 45 percent, 22 percent, 20 percent, 19 percent, and 12 percent, respectively, during the main to 50 years after identification.

Reasons for Doing this Study

Study of vascular dementia and other neurological disorder includes of various therapeutics used for the treatment of different neurological disorders. The bio-pharmaceutical companies are investing in the development of innovative therapeutics for the treatment of Neuro disorders. Government organizations square measure funding analysis and development activities associated with neurology analysis. These factors are impacting the neurology market positively coupled with the growing prevalence of neurological disorders. New approaches for the treatment of neurology related indications were pursued by pharmaceutical companies. The global neurology market is growing to increase within the population, growing awareness relating to mental and neurologic sickness, increasing insurance reforms and constant analysis and development in neurology by pharmaceutical companies.

Major Dementia Societies and Associations around Globe:

Alzheimer's Australia	Hilarescere Foundation in Italy
Foundation Alzheimer Aruba (FAA)	Alzheimer's disease Chinese
Spanish Society of Neurology	Alzheimer's Society
Major Neurological Associations in Italy	British brain tumor association

Top Neuroscience Universities in Globe:

Dalhousie University	University of Nottingham
Temple University USA	University of Toronto
University Oklahoma	University Sheffield
University of Bristol	University California
University of Milan	University of Gothenburg

Top Dementia Companies:

Brainomix	Polyneuron Pharmaceuticals AG Corp.
KB Medical	Intento SA
Trevena	AcelRx Pharmaceuticals, Inc.
Mintlabs	Mylan
Actavis	Bayer
Biogen Idec	Novartis

Being a significant expert in this area we would like to Invite you as an International Organizing Committee Members, Speakers, Keynote speakers, Young Research forum, Sponsors and Exhibitor, etc for Vascular Dementia 2023. Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Recent Advancement in Treating Dementia, Neurological Disorders, Anxiety & Depression, Neurology and Neurosurgery and share the cross-cultural experiences of various principles and practices.

The centre of the activity of Vascular Dementia 2023 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session.

Conference gives proper gratitude to Organizing Committee Members nimble of field various external professionals business enterprise councils and is obliged to different renowned personalities who interlocked with us and bolstered the symposium in each facet without which the convention might now not were possible. And bolstered the symposium in each facet without which the convention might now not were possible. Your reaction is our inspiration; preserving this motto in thoughts and being discovered the triumph of Vascular Dementia 2023.

The supporting journals include:

Journal of Neurology & Neurophysiology
Journal of Neurology and Neuroscience
Neurological Disorders

With the feedback from your renowned Speakers, we have added some of the new Session tracks that needs to be focused with Many sessions above.

Neurology related companies to have your gracious presence at “6th International Conference on Vascular Dementia and Movement Disorder” on December 04-05, 2023 | Dubai, UAE to make this congress a great successful event of the year 2023.

Contact us:

Kristina Kate

Program Manager

Vascular Dementia 2023

Website: https:// https://vascular-dementia.neurologyconference.com/

Mail us: kristinakate06@gmail.com

Tel: 441138682826

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date December 04-05, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Sponsorship Opportunities

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Sponsorship Form

Past Conference Report

VASCULAR DEMENTIA 2022 Conference

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Vascular Dementia & Movement Disorders

December 04-05, 2023 Dubai, UAE

Recent Advancements in the Field of Dementia Research

Vascular Dementia Conference 2023 | Vascular Dementia Congress | Alzheimer | Neurological Disorders | Dubai | UAE

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

VASCULAR DEMENTIA - 2023

About Conference

We are inviting you to “6^th International Conference on Vascular Dementia & Movement Disorders” during December 04-05, 2023 Dubai, UAE

Session & Tracks

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Vascular Dementia Conference 2023 | Vascular Dementia Congress | Alzheimer | Neurological Disorders | Dubai | UAE

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

VASCULAR DEMENTIA - 2023

About Conference

We are inviting you to “6th International Conference on Vascular Dementia & Movement Disorders” during December 04-05, 2023 Dubai, UAE

Session & Tracks

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

We are inviting you to “6^th International Conference on Vascular Dementia & Movement Disorders” during December 04-05, 2023 Dubai, UAE